Drug Shortage Report for APO-IRBESARTAN

Last updated on 2017-12-14 History
Report ID 342
Drug Identification Number 02386968
Brand name APO-IRBESARTAN
Common or Proper name IRBESARTAN
Company Name APOTEX INC
Active Ingredient(s) IRBESARTAN
Strength(s) 75MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-02-02
Estimated end date 2017-12-18
Actual end date 2017-12-11
Shortage status Resolved
Updated date 2017-12-14
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2017-12-14 French Compare
v10 2017-12-14 English Compare
v9 2017-12-06 French Compare
v8 2017-12-06 English Compare
v7 2017-11-27 French Compare
v6 2017-11-27 English Compare
v5 2017-10-16 French Compare
v4 2017-10-16 English Compare
v3 2017-10-16 English Compare
v2 2017-03-10 French Compare
v1 2017-03-10 English Compare